149 related articles for article (PubMed ID: 1976051)
1. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.
Windom HH; Burgess CD; Siebers RW; Purdie G; Pearce N; Crane J; Beasley R
Clin Pharmacol Ther; 1990 Sep; 48(3):296-301. PubMed ID: 1976051
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma.
Burgess CD; Windom HH; Pearce N; Marshall S; Beasley R; Siebers RW; Crane J
Am Rev Respir Dis; 1991 Feb; 143(2):444-6. PubMed ID: 1671326
[TBL] [Abstract][Full Text] [Related]
3. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.
Bremner P; Burgess C; Beasley R; Woodman K; Marshall S; Crane J; Pearce N
Respir Med; 1992 Sep; 86(5):419-23. PubMed ID: 1462021
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.
Wong CS; Pavord ID; Williams J; Britton JR; Tattersfield AE
Lancet; 1990 Dec; 336(8728):1396-9. PubMed ID: 1978872
[TBL] [Abstract][Full Text] [Related]
5. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
[TBL] [Abstract][Full Text] [Related]
6. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.
Bremner P; Siebers R; Crane J; Beasley R; Burgess C
Chest; 1996 Apr; 109(4):957-62. PubMed ID: 8635377
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
[TBL] [Abstract][Full Text] [Related]
8. Nebulized beta 2-adrenoceptor agonists do not affect plasma selenium or glutathione peroxidase activity in patients with asthma.
Burgess CD; Bremner P; Thomson CD; Crane J; Siebers RW; Beasley R
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):290-2. PubMed ID: 7921529
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
Crane J; Burgess C; Beasley R
Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
Scalabrin DM; Solé D; Naspitz CK
J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295
[TBL] [Abstract][Full Text] [Related]
11. [Effect of high doses of broncholytics on the state of cardiovascular system during treatment of sever exacerbation of bronchial asthma].
Makolkin VI; Ovcharenko SI; Peredel'skaia OA; Axel'rod AS
Kardiologiia; 2004; 44(2):65-9. PubMed ID: 15125428
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
[TBL] [Abstract][Full Text] [Related]
13. Effects of airway calibre on lung delivery of nebulised salbutamol.
Lipworth BJ; Clark DJ
Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
[TBL] [Abstract][Full Text] [Related]
14. [Comparative therapeutic effect of bronchodilator aerosols and salbutamol cyclocaps].
Ninković M; Bjelajac D; Ranković B; Dangubić V; Plavec G
Vojnosanit Pregl; 1993; 50(6):589-92. PubMed ID: 8197732
[TBL] [Abstract][Full Text] [Related]
15. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
Deenstra M; Haalboom JR; Struyvenberg A
Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
[TBL] [Abstract][Full Text] [Related]
16. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A; Lipworth BJ
Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
[TBL] [Abstract][Full Text] [Related]
17. Optimal dose of fenoterol by metered-dose inhaler in asthmatic adults.
Conrad SA; Light RW; George RB
Chest; 1986 Mar; 89(3):394-7. PubMed ID: 3512188
[TBL] [Abstract][Full Text] [Related]
18. Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol.
Sahlström K; Alanko K; Härkönen R
Respiration; 1986; 50 Suppl 2():302-9. PubMed ID: 2951826
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
[TBL] [Abstract][Full Text] [Related]
20. Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma.
Newhouse MT; Dolovich MB; Kazim F
Chest; 1994 Jun; 105(6):1738-42. PubMed ID: 8205869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
